titan phase 3 trial with apalutamide in metastatic castration sensitive prostate cancer
Published 2 years ago • 2.1K plays • Length 8:33Download video MP4
Download video MP3
Similar videos
-
3:06
titan trial
-
6:42
titan trial
-
1:34
dr. chi on the titan trial results in metastatic castration-sensitive prostate cancer
-
3:28
apalutamide and the titan clinical trial
-
1:38
kim n. chi, md, regarding key highlights from the final analysis of the phase iii titan study
-
7:17
understanding metastatic castration-resistant prostate cancer
-
2:50
live from asco: apalutamide for castration-sensitive prostate cancer
-
34:48
apalutamide in metastatic castration-sensitive prostate cancer (mcspc): a case-based discussion
-
0:54
apalutamide combination is well tolerated in metastatic castration-sensitive prostate cancer
-
1:46
dr. agarwal on the qol with apalutamide in metastatic castration-sensitive prostate cancer
-
10:00
results from acis trial of apalutamide abiraterone/prednisone in patients with chemo-naive mcrpc
-
15:06
comparing real world evidence to phase iii data on apalutamide for nmcrpc
-
12:42
pca commentary - nmcrpc and androgen receptor inhibition: enzalutamide, apalutamide and darolutamide
-
17:44
new approaches to metastatic hormone sensitive prostate cancer
-
1:20
nancy a. dawson, md, discusses outcomes from the titan study in mcspc
-
5:11
enzalutamide adt in men with de novo mhspc: the arches trial
-
11:07
phase 3 vision study of 177lupsma 617 for metastatic castration-resistant prostate cancer
-
31:13
titan trial | investigating the addition of apalutamide to androgen deprivation therapy
-
35:31
m0 space and the spartan trial